ClinVar Miner

Submissions for variant NM_000089.3(COL1A2):c.982G>A (p.Gly328Ser) (rs66612022)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000545434 SCV000627364 pathogenic Ehlers-Danlos syndrome, classic type; Osteogenesis imperfecta type I 2019-04-18 criteria provided, single submitter clinical testing This sequence change replaces glycine with serine at codon 328 of the COL1A2 protein (p.Gly328Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several individuals affected with osteogenesis imperfecta (OI) (PMID: 7860070, 22589248, 9272740, 16705691), and is a well-known cause of OI types III and IV (reviewed in PMID: 17078022). This variant is also known as p.Gly238Ser in the literature. Variants that affect the glycine residue in Gly-Xaa-Yaa repeats of the collagen triple helix are known to disrupt protein folding and stability. Experimental studies have shown that this missense variant results in the production of abnormal COL1A2 protein (PMID: 9272740, 7860070, 9594376). For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics,Fulgent Genetics RCV000763174 SCV000893765 pathogenic Osteogenesis imperfecta with normal sclerae, dominant form; Postmenopausal osteoporosis; Osteogenesis imperfecta, recessive perinatal lethal; Osteogenesis imperfecta type III; Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form; EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2 2018-10-31 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics,University Medical Centre Ljubljana RCV001196500 SCV001367108 pathogenic Recurrent fractures 2019-09-09 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5. This variant was detected in heterozygous state.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.